.
BioEnterprise

Gene Therapy Study for Duchenne Muscular Dystrophy Begins

Milo Biotechnology announced the first patient was treated with follistatin gene therapy at Nationwide Children’s Hospital in Columbus, Ohio, to treat Duchenne muscular dystrophy (DMD).

Read More  >